Cue Health Inc. (HLTHQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Apr 30, 2025
Cue Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 70.94 | 483.48 | 618.11 | 22.95 | 6.63 |
| Revenue Growth (YoY) | -85.33% | -21.78% | 2592.93% | 246.41% | - |
| Cost of Revenue | 265.71 | 501.43 | 319.37 | 43.43 | 21.41 |
| Gross Profit | -194.78 | -17.95 | 298.74 | -20.48 | -14.78 |
| Selling, General & Admin | 89.94 | 185.68 | 108.52 | 24.65 | 5.99 |
| Other Operating Expenses | -20.94 | - | - | - | - |
| Operating Expenses | 69 | 185.68 | 108.52 | 24.65 | 5.99 |
| Operating Income | -263.78 | -203.63 | 190.22 | -45.13 | -20.77 |
| Interest Expense | -1.16 | -0.65 | -9.81 | -0.37 | -0.15 |
| Interest & Investment Income | 6.24 | 3.33 | 0.11 | - | - |
| Other Non Operating Income (Expenses) | 0.16 | -0.84 | 0.22 | -1.24 | 0.31 |
| EBT Excluding Unusual Items | -258.53 | -201.78 | 180.74 | -46.74 | -20.61 |
| Merger & Restructuring Charges | -14.5 | -2.02 | - | - | - |
| Asset Writedown | -83.64 | - | - | - | - |
| Legal Settlements | -12 | - | - | - | - |
| Other Unusual Items | - | - | -61.56 | -0.61 | - |
| Pretax Income | -368.67 | -203.8 | 119.18 | -47.35 | -20.61 |
| Income Tax Expense | 4.79 | -9.75 | 32.76 | - | - |
| Net Income | -373.46 | -194.06 | 86.42 | -47.35 | -20.61 |
| Preferred Dividends & Other Adjustments | - | - | 53.31 | - | - |
| Net Income to Common | -373.46 | -194.06 | 33.11 | -47.35 | -20.61 |
| Shares Outstanding (Basic) | 153 | 148 | 53 | 16 | 16 |
| Shares Outstanding (Diluted) | 153 | 148 | 60 | 16 | 16 |
| Shares Change (YoY) | 3.28% | 148.22% | 265.51% | 3.52% | - |
| EPS (Basic) | -2.44 | -1.31 | 0.63 | -2.90 | -1.31 |
| EPS (Diluted) | -2.44 | -1.31 | 0.59 | -2.90 | -1.31 |
| Free Cash Flow | -146.98 | -162.1 | -118.3 | 16.62 | -15.94 |
| Free Cash Flow Per Share | -0.96 | -1.09 | -1.98 | 1.02 | -1.01 |
| Gross Margin | -274.58% | -3.71% | 48.33% | -89.21% | -223.04% |
| Operating Margin | -371.85% | -42.12% | 30.77% | -196.60% | -313.42% |
| Profit Margin | -526.48% | -40.14% | 5.36% | -206.30% | -310.99% |
| Free Cash Flow Margin | -207.20% | -33.53% | -19.14% | 72.41% | -240.58% |
| EBITDA | -219.2 | -160.66 | 222.75 | -38.94 | -17.11 |
| EBITDA Margin | - | -33.23% | 36.04% | -169.67% | -258.29% |
| D&A For EBITDA | 44.58 | 42.97 | 32.53 | 6.18 | 3.65 |
| EBIT | -263.78 | -203.63 | 190.22 | -45.13 | -20.77 |
| EBIT Margin | - | -42.12% | 30.77% | -196.60% | - |
| Effective Tax Rate | - | - | 27.49% | - | - |
| Revenue as Reported | 70.94 | 483.48 | 618.11 | 22.95 | 6.63 |
| Advertising Expenses | 2.9 | 42.3 | 15.4 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.